Varela M - Search Results

1

Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma.

Varela M, Sala M, Llovet JM, Bruix J. Varela M, et al. Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:98-102. doi: 10.1046/j.1365-2036.17.s2.11.x. Aliment Pharmacol Ther. 2003. PMID: 12786620 Review.

2

Treatment of hepatocellular carcinoma: is there an optimal strategy?

Varela M, Sala M, Llovet JM, Bruix J. Varela M, et al. Cancer Treat Rev. 2003 Apr;29(2):99-104. doi: 10.1016/s0305-7372(02)00123-8. Cancer Treat Rev. 2003. PMID: 12670452 Review.

3

Pseudotumoral hepatic tuberculosis.

Varela M, Fernández J, Navasa M, Bruix J. Varela M, et al. J Hepatol. 2003 Oct;39(4):654. doi: 10.1016/s0168-8278(03)00401-x. J Hepatol. 2003. PMID: 12971980 No abstract available.

4

High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

Sala M, Fuster J, Llovet JM, Navasa M, Solé M, Varela M, Pons F, Rimola A, García-Valdecasas JC, Brú C, Bruix J; Barcelona Clinic Liver Cancer (BCLC) Group. Sala M, et al. Among authors: varela m. Liver Transpl. 2004 Oct;10(10):1294-300. doi: 10.1002/lt.20202. Liver Transpl. 2004. PMID: 15376311 Free article.

5

Selection of candidates with HCC for transplantation in the MELD era.

Sala M, Varela M, Bruix J. Sala M, et al. Among authors: varela m. Liver Transpl. 2004 Oct;10(10 Suppl 2):S4-9. doi: 10.1002/lt.20263. Liver Transpl. 2004. PMID: 15382217 Free article. Review.

6

[Early diagnosis of liver cancer].

Sala M, Varela M, Forner A, Bruix J. Sala M, et al. Among authors: varela m. Gastroenterol Hepatol. 2005 May;28(5):292-7. doi: 10.1157/13074066. Gastroenterol Hepatol. 2005. PMID: 15871814 Review. Spanish.

7

Prognostic prediction in patients with hepatocellular carcinoma.

Sala M, Forner A, Varela M, Bruix J. Sala M, et al. Among authors: varela m. Semin Liver Dis. 2005;25(2):171-80. doi: 10.1055/s-2005-871197. Semin Liver Dis. 2005. PMID: 15918146 Review.

8

Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipients.

Varela M, Bruix J. Varela M, et al. J Hepatol. 2006 Jan;44(1):8-10. doi: 10.1016/j.jhep.2005.11.001. Epub 2005 Nov 8. J Hepatol. 2006. PMID: 16297492 No abstract available.

9

Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?

Vilana R, Bianchi L, Varela M, Nicolau C, Sánchez M, Ayuso C, García M, Sala M, Llovet JM, Bruix J, Bru C; BCLC Group. Vilana R, et al. Among authors: varela m. Eur Radiol. 2006 Nov;16(11):2454-62. doi: 10.1007/s00330-006-0264-8. Epub 2006 May 18. Eur Radiol. 2006. PMID: 16710666

10

Hepatocellular carcinoma in the setting of liver transplantation.

Varela M, Sanchez W, Bruix J, Gores GJ. Varela M, et al. Liver Transpl. 2006 Jul;12(7):1028-36. doi: 10.1002/lt.20833. Liver Transpl. 2006. PMID: 16799950 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

849 results

Search Page

Filters